Artis Biosolutions
1 known investors
Artis BioSolutions develops synthetic DNA and provides integrated manufacturing services for genetic medicine and advanced therapeutic modalities, including cell therapy, gene therapy, mRNA, gene editing, and vaccines. The company serves genetic medicine developers seeking to accelerate clinical development and GMP manufacturing within a single quality framework.
Founders & leadership
BN
Brian Neel
MH
Mike Houston
KB
Kate Broderick
ES
Eric Stier
PS
Peter Stolba
GN
Gregg Nyberg
Investors · 1
Competitors · 2
by search overlap
Fortis Life Sciences13 shared keywordsFortis Life Sciences develops and manufactures Bethyl-branded ELISA kits and related reagents, buffers, and antibodies for detecting target proteins in research and diagnostic applications. The kits cover human and veterinary targets and are made in the USA using the company's own antibodies.
IQVIA7 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.
Companies competing with Artis Biosolutions for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Artis Biosolutions do?
- Artis BioSolutions develops synthetic DNA and provides integrated manufacturing services for genetic medicine and advanced therapeutic modalities, including cell therapy, gene therapy, mRNA, gene editing, and vaccines. The company serves genetic medicine developers seeking to accelerate clinical development and GMP manufacturing within a single quality framework.
- Who are Artis Biosolutions's investors?
- Artis Biosolutions's investors include Oak HC/FT.